ZK824859 is primarily utilized in research settings, particularly in the field of oncology. It has shown potential as an inhibitor targeting specific pathways involved in cancer cell proliferation. Studies have focused on its ability to disrupt signaling mechanisms that promote tumor growth, making it a candidate for further investigation in cancer therapy. Additionally, it is being explored for its role in enhancing the efficacy of existing treatments when used in combination therapies. Its application is still largely confined to preclinical studies, where its safety and effectiveness are being rigorously evaluated.